Meningioma Related Epilepsy- Pathophysiology, Pre/postoperative Seizures Predicators and Treatment

Rasha Elbadry Ahmed1, Hailiang Tang2, Anthony Asemota1

  • 1Department of Neurosurgery, Loma Linda University Medical Center, Loma Linda, CA, United States.

Frontiers in Oncology
|July 21, 2022
PubMed

Insights

Meningiomas, common brain tumors, often cause seizures impacting quality of life. Understanding seizure predictors aids better management and surgical outcomes for patients.

Area of Science:

  • Neurology
  • Neurosurgery
  • Oncology

Background:

  • Meningiomas are the most common primary brain tumors, comprising approximately 30% of all intracranial neoplasms.
  • While often benign and surgically curable, meningiomas can cause significant symptoms, including seizures, affecting patient quality of life.
  • Seizures occur in about 30% of meningioma cases, persisting post-surgery in 12-19% despite treatment.

Purpose of the Study:

  • To identify predictors of pre- and post-operative seizures in meningioma patients.
  • To enhance understanding of factors influencing seizure likelihood in this population.
  • To guide more effective seizure control strategies and risk assessment before and after surgical intervention.

Main Methods:

  • Literature review of studies identifying potential predictors of seizures in meningioma patients.
  • Analysis of factors associated with pre-operative and post-operative seizure occurrence.
  • Synthesis of findings to inform clinical management and patient counseling.

Main Results:

  • Established predictors for seizures in meningioma patients have been identified in existing literature.
  • Understanding these predictors is crucial for managing seizure frequency and severity.
  • Factors influencing seizure likelihood require further investigation for comprehensive patient care.

Conclusions:

  • Identifying seizure predictors in meningioma patients is vital for improving patient outcomes.
  • Effective seizure management strategies can be developed by understanding pre- and post-operative factors.
  • Further research into seizure likelihood factors will aid in personalized treatment approaches for meningioma patients.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
271
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
575
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
598
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
501
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
269